HEALTHCARE
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British...
Subscribe
– Stay updated in real-time
– Get in-depth insights and trends
– News straight to your inbox
Must read